Kazuichi Okazaki
Overview
Explore the profile of Kazuichi Okazaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
467
Citations
9600
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito T, Ikeura T, Nakamaru K, Masuda M, Nakayama S, Shimatani M, et al.
Pancreas
. 2025 Feb;
PMID: 40019478
Objectives: Autoimmune pancreatitis (AIP) is a pancreatic manifestation of IgG4-related disease which is complicated by extra-pancreatic lesions such as IgG4-related sclerosing cholangitis. The appropriate biliary drainage method and period for...
2.
Sano T, Kikuta K, Takikawa T, Matsumoto R, Okazaki K, Takeyama Y, et al.
Pancreatology
. 2024 Dec;
25(1):82-88.
PMID: 39643518
Background/objective: Elevated serum IgG4 (sIgG4) is a useful diagnostic marker of type 1 autoimmune pancreatitis (AIP). This study aimed to clarify the clinicopathological characteristics of the type 1 AIP patients...
3.
Yamamoto M, Kanda M, Mizushima I, Kanno A, Umemura T, Ikeura T, et al.
Immunol Med
. 2024 Nov;
:1-11.
PMID: 39607031
We started a registry for cases of immunoglobulin (Ig)G4-related disease (IgG4-RD) in December 2019 to clarify the clinical profile of IgG4-RD. In this study, clinical information from 854 cases registered...
4.
Stone J, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, et al.
N Engl J Med
. 2024 Nov;
PMID: 39541094
Background: IgG4-related disease is a multiorgan, relapsing, fibroinflammatory, immune-mediated disorder with no approved therapy. Inebilizumab targets and depletes CD19+ B cells and may be effective for treating patients with IgG4-related...
5.
Tanaka M, Maeba H, Senoo T, Yoshimiya N, Ozaki H, Uchitani K, et al.
J Pharm Health Care Sci
. 2024 Oct;
10(1):63.
PMID: 39375816
Background: Morphine is effective in palliative care for patients with end-stage heart failure; however, its use is avoided in patients with impaired renal function because it tends to induce adverse...
6.
Hirono S, Higuchi R, Honda G, Nara S, Esaki M, Gotohda N, et al.
Ann Gastroenterol Surg
. 2024 Sep;
8(5):845-859.
PMID: 39229554
Background: Surgical resection is standard treatment for invasive intraductal papillary mucinous carcinoma (IPMC); however, impact of multidisciplinary treatment on survival including postoperative adjuvant therapy (AT), neoadjuvant therapy (NAT), and treatment...
7.
Suzuki S, Omori Y, Ono Y, Hirose K, Itoh T, Karasaki H, et al.
Ann Surg
. 2024 Jul;
PMID: 39016004
Objective: This study aimed to clarify the molecular mechanism of remnant pancreatic cancer (PC) development after primary PC resection. Summary Background Data: Molecular mechanisms of the development of remnant PCs...
8.
Hijioka S, Yamashige D, Esaki M, Honda G, Higuchi R, Masui T, et al.
Clin Gastroenterol Hepatol
. 2024 Apr;
22(7):1416-1426.e5.
PMID: 38615727
Background & Aims: Despite previously reported treatment strategies for nonfunctioning small (≤20 mm) pancreatic neuroendocrine neoplasms (pNENs), uncertainties persist. We aimed to evaluate the surgically resected cases of nonfunctioning small...
9.
Takikawa T, Kikuta K, Sano T, Ikeura T, Fujimori N, Umemura T, et al.
Pancreatology
. 2024 Feb;
24(3):335-342.
PMID: 38336506
Background/objectives: The association between autoimmune pancreatitis (AIP) and pancreatic cancer (PC) remains controversial. This study aimed to clarify the long-term prognosis and risk of malignancies in AIP patients in Japan....
10.
Terao C, Ota M, Iwasaki T, Shiokawa M, Kawaguchi S, Kuriyama K, et al.
Lancet Rheumatol
. 2024 Jan;
1(1):e14-e22.
PMID: 38229354
Background: IgG4-related disease is a newly recognised immunopathological entity that includes autoimmune pancreatitis, IgG4-related sialadenitis, and IgG4-related kidney disease. To understand the genetic landscape of IgG4-related disease, we did a...